Immune-Onc Therapeutics
2 known investors
Immune Onc is a biotechnology company developing medicines to treat patients with hard-to-treat cancers and autoimmune diseases, with expertise in translational medicine and clinical development.
BiotechMedical Devices
Investors · 2
In the news
- Immune-Onc Therapeutics Announces Close of Series B Extension Financing, Bringing Total Round to $131 Million — Immune-Onc Therapeuticsimmune-onc.com · 2023
- Immune-Onc Therapeutics - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Immune-Onc Therapeutics - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2021
- LLS TAP Announces Five New Investments Supporting Next Generation Immunotherapies — Immune-Onc Therapeuticsimmune-onc.com · 2021
- Immune-Onc Therapeutics Raises More Than $33M in Series B Fundingfinsmes.com · 2018
- Immune-Onc Therapeutics Raises $7M in Series A Financing - FinSMEsfinsmes.com · 2016